Literature DB >> 8622921

The C-terminal region of human angiogenin has a dual role in enzymatic activity.

N Russo1, V Nobile, A Di Donato, J F Riordan, B L Vallee.   

Abstract

The ribonucleolytic activity of angiogenin (Ang) is essential to Ang's capacity to induce blood vessel formation. Previous x-ray diffraction and mutagenesis results have shown that the active site of the human protein is obstructed by Gln-117 and imply that the C-terminal region of Ang must undergo a conformational rearrangement to allow substrate binding and catalysis. As a first step toward structural characterization of this conformational change, additional site-directed mutagenesis and kinetic analysis have been used to examine the intramolecular interactions that stabilize the inactive conformation of the protein. Two residues of this region, Ile-119 and Phe-120, are found to make hydrophobic interactions with the remainder of the protein and thereby help to keep Gln-117 in its obstructive position. Furthermore, the suppression of activity by the intramolecular interactions of Ile-119 and Phe-120 is counterbalanced by an effect of the adjacent residues, Arg-121, Arg-122, and Pro-123 which do not appear to form contacts with the rest of the protein structure. They contribute to enzymatic activity, probably by constituting a peripheral subsite for binding polymeric substrates. The results reveal the nature of the conformational change in human Ang and assign a key role to the C-terminal region both in this process and, presumably, in the regulation of human Ang function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622921      PMCID: PMC39590          DOI: 10.1073/pnas.93.8.3243

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Molecular evolution of the ribonuclease superfamily.

Authors:  J J Beintema; C Schüller; M Irie; A Carsana
Journal:  Prog Biophys Mol Biol       Date:  1988       Impact factor: 3.667

2.  Characteristic ribonucleolytic activity of human angiogenin.

Authors:  R Shapiro; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

3.  A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.

Authors:  J W Harper; B L Vallee
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

4.  Structure of phosphate-free ribonuclease A refined at 1.26 A.

Authors:  A Wlodawer; L A Svensson; L Sjölin; G L Gilliland
Journal:  Biochemistry       Date:  1988-04-19       Impact factor: 3.162

5.  Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNAs.

Authors:  S M Rybak; B L Vallee
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

6.  A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.

Authors:  N Russo; K R Acharya; B L Vallee; R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Isolation of angiogenin from normal human plasma.

Authors:  R Shapiro; D J Strydom; K A Olson; B L Vallee
Journal:  Biochemistry       Date:  1987-08-11       Impact factor: 3.162

8.  Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis.

Authors:  R Shapiro; E A Fox; J F Riordan
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

9.  Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin.

Authors:  J W Harper; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues.

Authors:  R Shapiro; S Weremowicz; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more
  5 in total

1.  Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies.

Authors:  Daniel E Holloway; Gayatri B Chavali; Michelle C Hares; Vasanta Subramanian; K Ravi Acharya
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-11-19

2.  Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.

Authors:  D D Leonidas; G B Chavali; A M Jardine; S Li; R Shapiro; K R Acharya
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 3.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

4.  Structural insights into human angiogenin variants implicated in Parkinson's disease and Amyotrophic Lateral Sclerosis.

Authors:  William J Bradshaw; Saima Rehman; Tram T K Pham; Nethaji Thiyagarajan; Rebecca L Lee; Vasanta Subramanian; K Ravi Acharya
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

5.  Nucleotide substrate binding characterization in human pancreatic-type ribonucleases.

Authors:  Khushboo Bafna; Chitra Narayanan; S Chakra Chennubhotla; Nicolas Doucet; Pratul K Agarwal
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.